Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odd Lilleng Gammelgaard

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|February 2, 2024
Odd Lilleng Gammelgaard, Per Guldberg, Morten F Gjerstorff, et al.
Journal for Immunotherapy of Cancer|December 4, 2025
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trialOdd Lilleng Gammelgaard, Sidse Ehmsen, Anne Marie Bak Jylling, et al.
Frontiers in Oncology|October 24, 2022
SSX addiction in melanoma propagates tumor growth and metastasisSofie Traynor, Malene Laage Ebstrup, Odd Lilleng Gammelgaard, et al.
Cancer Letters|October 29, 2022
DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1Sofie Traynor, Mikkel Green Terp, Aaraby Yoheswaran Nielsen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|February 2, 2024
Odd Lilleng Gammelgaard, Per Guldberg, Morten F Gjerstorff, et al.
Journal for Immunotherapy of Cancer|December 4, 2025
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trialOdd Lilleng Gammelgaard, Sidse Ehmsen, Anne Marie Bak Jylling, et al.
Frontiers in Oncology|October 24, 2022
SSX addiction in melanoma propagates tumor growth and metastasisSofie Traynor, Malene Laage Ebstrup, Odd Lilleng Gammelgaard, et al.
Cancer Letters|October 29, 2022
DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1Sofie Traynor, Mikkel Green Terp, Aaraby Yoheswaran Nielsen, et al.
Pageof 1